title: Long-term variations of serum beta 2-microglobulin levels in hemodialysed uremics according to permeability and bioincompatibility of dialysis membranes.
abstract: Hemodialysis (HD) amyloidosis is due to beta 2-microglobulin (beta 2M) storage, the importance of which could vary with the permeability of dialysis membranes. We studied long-term variations of beta 2M in 52 patients who had been dialyzed over 1.5-20 years (mean +/- SD = 7.5 +/- 5.2), 3 X 4 h weekly. Serum samples had been stored at 30 degrees C and RIAs were done in one run with the same kits (Immunotech). At least 2 assays were done for each patient in samples collected 1-9.5 years apart. Mean beta 2M concentration in 26 ESRF patients was 31 +/- 18 mg/l. According to duration of HD and membranes used, Cuprophan (CUP) versus polyacrylonitrile (AN69), mean concentrations of beta 2M were (mg/l +/- SD): at 6 months, 55 +/- 36 vs. 54 +/- 20 (n.s.); 2 years, 55 +/- 24 vs. 61 +/- 23 (n.s.); 4 years, 79 +/- 18 vs. 64 +/- 19 (n.s.); 6 years, 69 +/- 17 vs. 55 +/- 17 (n.s.); 8 years, 76 +/- 18 vs. 54 +/- 12 (less than 0.01); 10 years, 77 +/- 17 vs. 54 +/- 14 (less than 0.02). The effect of changing membranes was also studied: CUP-AN69 (69 +/- 28 months), 79 +/- 21 vs. 54 +/- 14 (less than 0.01). Serum beta 2M (1) increased rapidly after the beginning of HD; (2) reached a plateau after 2 years in patients treated with AN69 and 4 years with CUP; (3) were significantly lower after 8 years with AN69 than with CUP, and (4) decreased significantly after changing CUP for AN69.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Nephrology, La Beauchée Hospital, Saint-Brieuc, France.
authors.forename: P
authors.initials: P
authors.lastname: Simon
authors.forename: Y Y
authors.initials: YY
authors.lastname: Cavarle
authors.forename: K S
authors.initials: KS
authors.lastname: Ang
authors.forename: G
authors.initials: G
authors.lastname: Cam
authors.forename: M
authors.initials: M
authors.lastname: Catheline
mesh_terms: D001672:Biocompatible Materials; D005260:Female; D006801:Humans; D008297:Male; D008567:Membranes, Artificial; D009994:Osmolar Concentration; D010539:Permeability; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation; D013997:Time Factors; D014511:Uremia / Q000628:therapy*; D001613:beta 2-Microglobulin / Q000378:metabolism*
chemical_list: D001672:Biocompatible Materials; D008567:Membranes, Artificial; D001613:beta 2-Microglobulin